Johnson & Johnson Family of Companies
United States
2690 articles about Johnson & Johnson Family of Companies
-
Johnson & Johnson CFO Says Child Medication Recall Could Cost up to $300 Million
5/12/2010
-
Congress Probing Johnson & Johnson Children's Tylenol Recall
5/6/2010
-
FDA Finds Grime at Johnson & Johnson Plant, Urges Use of Generics
5/5/2010
-
Johnson & Johnson Wins North American Corporate Excellence Award for EAP; A ValueOptions(R) Supported Program Wins for Fourth Time Since 2005
5/4/2010
-
Johnson & Johnson to Participate in Bank of America Merrill Lynch 2010 Health Care Conference
5/4/2010
-
Johnson & Johnson to Pay Over $81 Million in Topamax Drug Case
4/29/2010
-
Johnson & Johnson to Participate in Deutsche Bank 35th Annual Health Care Conference
4/27/2010
-
Medical Device Sales Stoke Johnson & Johnson Earnings
4/20/2010
-
Johnson & Johnson Says FDA Rejected 'Sedasys' Sedation System
4/20/2010
-
Johnson & Johnson 1Q Profit Up 29%; Cuts EPS View
4/20/2010
-
Device, Drugmaker Johnson & Johnson Needs Revenue To Rebound; Investors Also Watching Health Reform Impact
4/19/2010
-
"Warehoused" Hepatitis C Patients May Boost Merck & Co., Inc., Johnson & Johnson, Vertex Pharmaceuticals (CA)
4/19/2010
-
Johnson & Johnson Shows Door to 80 Execs; Most Jobs Cut at Mid-management Level
4/16/2010
-
FDA, Johnson & Johnson. Pfizer Inc., Merck & Co., Inc., and Novartis Corporation Present Best Practices at Adaptive Designs for Clinical Drug Development
4/16/2010
-
Johnson & Johnson to Webcast Annual Meeting of Shareholders
4/15/2010
-
U.S. FDA Approves Johnson & Johnson's Pancreaze Delayed Release Capsules
4/13/2010
-
Johnson & Johnson Reviewing Offer for Breast-Care Division; Amount of Offer Not Disclosed
3/31/2010
-
U.S. Panel Sees Amgen And Johnson & Johnson Anemia Drug Risks In Kidney Patients
3/25/2010
-
NexMed to Co-Sponsor Biotalk of Dr. Diego Miralles of Johnson & Johnson at the San Diego Biotechnology Discussion Group
3/25/2010
-
Johnson & Johnson CEO Weldon Gets 11% 2009 Raise, to $25.6 Million
3/18/2010